Market Overview:
The global COVID-19 diagnostics market size reached US$
94.5 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$
32.1 Billion by 2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different
end use sectors. These insights are included in the report as a major market contributor.
COVID-19 diagnostics refer to the clinical tests conducted to detect the presence of the viral infection among individuals. COVID-19 is an infectious disease caused by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat and body aches. The viral infection is usually diagnosed through reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing. These tests use reagents and kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP) and nasal swabs, human saliva or blood. They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.
The sudden outbreak of coronavirus disease and an alarming increase in the number of COVID-19 cases across the globe are among the key factors creating a positive outlook for the market growth. The continuous rise in the number of daily cases has led to the widespread adoption of diagnostic tests for rapid and comprehensive testing to provide early treatment to the patients. In line with this, the increasing demand for mass testing and molecular diagnostics is contributing to the market growth. Additionally, various product innovations, such as the launch of novel antibody and serology test kits for home-testing, are acting as other growth-inducing factors. In comparison to the traditionally used testing kits, these variants are less time-consuming and can be integrated with software-based programs for accurate results. Other factors, including the implementation of favorable government polices to prevent the further spread of COVID-19 infection, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global COVID-19 diagnostics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, sample type, test type, mode and end use.
Breakup by Product Type:
- Reagents and Kits
- Instruments
- Others
Breakup by Sample Type:
- Nasopharyngeal Swabs
- Oropharyngeal Swabs
- Nasal Swabs
- Blood
- Others
Breakup by Test Type:
- Molecular (RT-PCR) Testing
- Antigen-based Testing
- Antibody (Serology) Testing
- Others
Breakup by Mode:
- Point-of-Care (PoC)
- Non-Point-of-Care (Non-PoC)
Breakup by End Use:
- Laboratories
- Hospitals
- Diagnostic Centers and Clinics
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd. (Roche Holding AG), Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Robert Bosch GmbH, Seegene Inc., Siemens Aktiengesellschaft and Thermo Fisher Scientific Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Product Type, Sample Type, Test Type, Mode, End Use, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd. (Roche Holding AG), Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Robert Bosch GmbH, Seegene Inc., Siemens Aktiengesellschaft and Thermo Fisher Scientific Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global COVID-19 diagnostics market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the sample type?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the mode?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global COVID-19 diagnostics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global COVID-19 Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Reagents and Kits
6.1.1 Market Trends and Forecast
6.2 Instruments
6.2.1 Market Trends and Forecast
6.3 Others
6.3.1 Market Trends and Forecast
7 Market Breakup by Sample Type
7.1 Nasopharyngeal Swabs
7.1.1 Market Trends and Forecast
7.2 Oropharyngeal Swabs
7.2.1 Market Trends and Forecast
7.3 Nasal Swabs
7.3.1 Market Trends and Forecast
7.4 Blood
7.4.1 Market Trends and Forecast
7.5 Others
7.5.1 Market Trends and Forecast
8 Market Breakup by Test Type
8.1 Molecular (RT-PCR) Testing
8.1.1 Market Trends and Forecast
8.2 Antigen-based Testing
8.2.1 Market Trends and Forecast
8.3 Antibody (Serology) Testing
8.3.1 Market Trends and Forecast
8.4 Others
8.4.1 Market Trends and Forecast
9 Market Breakup by Mode
9.1 Point-of-Care (PoC)
9.1.1 Market Trends and Forecast
9.2 Non-Point-of-Care (Non-PoC)
9.2.1 Market Trends and Forecast
10 Market Breakup by End Use
10.1 Laboratories
10.1.1 Market Trends and Forecast
10.2 Hospitals
10.2.1 Market Trends and Forecast
10.3 Diagnostic Centers and Clinics
10.3.1 Market Trends and Forecast
10.4 Others
10.4.1 Market Trends and Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends and Forecast
11.1.2 Canada
11.1.2.1 Market Trends and Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends and Forecast
11.2.2 Japan
11.2.2.1 Market Trends and Forecast
11.2.3 India
11.2.3.1 Market Trends and Forecast
11.2.4 South Korea
11.2.4.1 Market Trends and Forecast
11.2.5 Australia
11.2.5.1 Market Trends and Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends and Forecast
11.2.7 Others
11.2.7.1 Market Trends and Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends and Forecast
11.3.2 France
11.3.2.1 Market Trends and Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends and Forecast
11.3.4 Italy
11.3.4.1 Market Trends and Forecast
11.3.5 Spain
11.3.5.1 Market Trends and Forecast
11.3.6 Russia
11.3.6.1 Market Trends and Forecast
11.3.7 Others
11.3.7.1 Market Trends and Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends and Forecast
11.4.2 Mexico
11.4.2.1 Market Trends and Forecast
11.4.3 Others
11.4.3.1 Market Trends and Forecast
11.5 Middle East and Africa
11.5.1 Market Trends and Forecast
11.5.2 Market Breakup by Country
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott Laboratories
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Becton Dickinson and Company
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 bioMérieux SA
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Bio-Rad Laboratories
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Danaher Corporation
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 F. Hoffman-La Roche Ltd. (Roche Holding AG)
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.7 Luminex Corporation
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 PerkinElmer Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Quest Diagnostics Incorporated
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Robert Bosch GmbH
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Seegene Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.12 Siemens Aktiengesellschaft
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 Thermo Fisher Scientific Inc.
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
16.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: COVID-19 Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: COVID-19 Diagnostics Market: Sales Value (in Billion US$), 2021-2027
Figure 3: Global: COVID-19 Diagnostics Market: Breakup by Product Type (in %), 2021
Figure 4: Global: COVID-19 Diagnostics Market: Breakup by Sample Type (in %), 2021
Figure 5: Global: COVID-19 Diagnostics Market: Breakup by Test Type (in %), 2021
Figure 6: Global: COVID-19 Diagnostics Market: Breakup by Mode (in %), 2021
Figure 7: Global: COVID-19 Diagnostics Market: Breakup by End Use (in %), 2021
Figure 8: Global: COVID-19 Diagnostics Market: Breakup by Region (in %), 2021
Figure 9: Global: COVID-19 Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2021-2027
Figure 10: Global: COVID-19 Diagnostics (Instruments) Market: Sales Value (in Million US$), 2021-2027
Figure 11: Global: COVID-19 Diagnostics (Other Product Types) Market: Sales Value (in Million US$), 2021-2027
Figure 12: Global: COVID-19 Diagnostics (Nasopharyngeal Swabs) Market: Sales Value (in Million US$), 2021-2027
Figure 13: Global: COVID-19 Diagnostics (Oropharyngeal Swabs) Market: Sales Value (in Million US$), 2021-2027
Figure 14: Global: COVID-19 Diagnostics (Nasal Swabs) Market: Sales Value (in Million US$), 2021-2027
Figure 15: Global: COVID-19 Diagnostics (Blood) Market: Sales Value (in Million US$), 2021-2027
Figure 16: Global: COVID-19 Diagnostics (Other Sample Types) Market: Sales Value (in Million US$), 2021-2027
Figure 17: Global: COVID-19 Diagnostics (Molecular/RT-PCR Testing) Market: Sales Value (in Million US$), 2021-2027
Figure 18: Global: COVID-19 Diagnostics (Antigen-based Testing) Market: Sales Value (in Million US$), 2021-2027
Figure 19: Global: COVID-19 Diagnostics (Antibody-Testing- Serology) Market: Sales Value (in Million US$), 2021-2027
Figure 20: Global: COVID-19 Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2021-2027
Figure 21: Global: COVID-19 Diagnostics (Point-of-Care - PoC) Market: Sales Value (in Million US$), 2021-2027
Figure 22: Global: COVID-19 Diagnostics (Non-Point-of-Care - Non-PoC) Market: Sales Value (in Million US$), 2021-2027
Figure 23: Global: COVID-19 Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2021-2027
Figure 24: Global: COVID-19 Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2021-2027
Figure 25: Global: COVID-19 Diagnostics (Diagnostic Centers and Clinics) Market: Sales Value (in Million US$), 2021-2027
Figure 26: Global: COVID-19 Diagnostics (Other End Uses) Market: Sales Value (in Million US$), 2021-2027
Figure 27: North America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 28: United States: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 29: Canada: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 30: Asia-Pacific: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 31: China: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 32: Japan: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 33: India: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 34: South Korea: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 35: Australia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 36: Indonesia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 37: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 38: Europe: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 39: Germany: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 40: France: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 41: United Kingdom: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 42: Italy: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 43: Spain: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 44: Russia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 45: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 46: Latin America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 47: Brazil: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 48: Mexico: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 49: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 50: Middle East and Africa: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2021-2027
Figure 51: Middle East and Africa: COVID-19 Diagnostics Market: Breakup by Country (in %), 2021
Figure 52: Global: COVID-19 Diagnostics Industry: SWOT Analysis
Figure 53: Global: COVID-19 Diagnostics Industry: Value Chain Analysis
Figure 54: Global: COVID-19 Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: COVID-19 Diagnostics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: COVID-19 Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 3: Global: COVID-19 Diagnostics Market Forecast: Breakup by Sample Type (in Million US$), 2022-2027
Table 4: Global: COVID-19 Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2022-2027
Table 5: Global: COVID-19 Diagnostics Market Forecast: Breakup by Mode (in Million US$), 2022-2027
Table 6: Global: COVID-19 Diagnostics Market Forecast: Breakup by End Use (in Million US$), 2022-2027
Table 7: Global: COVID-19 Diagnostics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 8: Global: COVID-19 Diagnostics Market: Competitive Structure
Table 9: Global: COVID-19 Diagnostics Market: Key Players